Cargando…
Autoimmunity to annexin A2 predicts mortality among hospitalised COVID-19 patients
Levels of anti-annexin A2 antibodies at admission strongly predicted mortality among hospitalised COVID-19 patients. Given its critical protective function in the lung, annexin A2 antagonism may play an important role in the pathophysiology of COVID-19. https://bit.ly/2UMPr9w
Autores principales: | Zuniga, Marisol, Gomes, Claudia, Carsons, Steven E., Bender, Michael T., Cotzia, Paolo, Miao, Qing Robert, Lee, David C., Rodriguez, Ana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859972/ https://www.ncbi.nlm.nih.gov/pubmed/34244321 http://dx.doi.org/10.1183/13993003.00918-2021 |
Ejemplares similares
-
Impact of socioeconomic status in patients hospitalised for COVID-19 in the Greater Paris area
por: Sesé, Lucile, et al.
Publicado: (2020) -
Low physical functioning and impaired performance of activities of daily life in COVID-19 patients who survived hospitalisation
por: Belli, Stefano, et al.
Publicado: (2020) -
Does a single Pseudomonas
aeruginosa isolation predict COPD mortality?
por: Boutou, Afroditi K., et al.
Publicado: (2014) -
Risk factors for mortality in patients with COVID-19 needing extracorporeal respiratory support
por: Riera, Jordi, et al.
Publicado: (2022) -
Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2
por: Du, Rong-Hui, et al.
Publicado: (2020)